Financial Counselors Inc Charles River Laboratories International, Inc. Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

A detailed history of Financial Counselors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Financial Counselors Inc holds 26,592 shares of CRL stock, worth $5.31 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

26,592

Previous 21,696 22.57%

Holding current value

$5.31 Million

Previous $4.48 Million 16.89%

% of portfolio

0.08%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $920,252 - $1.2 Million	4,896 Added 22.57%	26,592 $5.24 Million
Q2 2024 Aug 01, 2024	BUY	$206.39 - $268.73 $114,546 - $149,145	555 Added 2.63%	21,696 $4.48 Million
Q1 2024 May 02, 2024	SELL	$203.52 - $273.43 $3,866 - $5,195	-19 Reduced 0.09%	21,141 $5.73 Million
Q4 2023 Jan 26, 2024	SELL	$164.52 - $238.84 $231,150 - $335,570	-1,405 Reduced 6.23%	21,160 $5 Million
Q3 2023 Nov 07, 2023	BUY	$194.44 - $217.61 $192,884 - $215,869	992 Added 4.6%	22,565 $4.42 Million
Q2 2023 Jul 27, 2023	SELL	$183.71 - $210.25 $213,471 - $244,310	-1,162 Reduced 5.11%	21,573 $4.54 Million
Q1 2023 May 02, 2023	SELL	$191.89 - $259.92 $695,409 - $941,950	-3,624 Reduced 13.75%	22,735 $4.59 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $231,998 - $294,332	-1,177 Reduced 4.27%	26,359 $5.74 Million
Q3 2022 Nov 01, 2022	BUY	$182.44 - $250.54 $544,765 - $748,112	2,986 Added 12.16%	27,536 $5.42 Million
Q2 2022 Aug 02, 2022	BUY	$204.13 - $302.4 $153,097 - $226,799	750 Added 3.15%	24,550 $5.25 Million
Q1 2022 Apr 28, 2022	BUY	$255.51 - $362.11 $373,555 - $529,404	1,462 Added 6.54%	23,800 $6.76 Million
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $790,253 - $1.01 Million	2,249 Added 11.2%	22,338 $8.42 Million
Q3 2021 Oct 26, 2021	SELL	$372.64 - $458.3 $828,006 - $1.02 Million	-2,222 Reduced 9.96%	20,089 $8.29 Million
Q2 2021 Aug 03, 2021	BUY	$294.17 - $371.65 $110,902 - $140,112	377 Added 1.72%	22,311 $8.25 Million
Q1 2021 Apr 29, 2021	BUY	$249.67 - $299.48 $1.08 Million - $1.29 Million	4,309 Added 24.45%	21,934 $6.36 Million
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $189,810 - $215,990	855 Added 5.1%	17,625 $4.4 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $122,365 - $157,835	697 Added 4.34%	16,770 $3.8 Million
Q2 2020 Aug 07, 2020	BUY	$118.84 - $189.72 $325,502 - $519,643	2,739 Added 20.54%	16,073 $2.8 Million
Q1 2020 Apr 23, 2020	BUY	$98.9 - $178.34 $518,730 - $935,393	5,245 Added 64.84%	13,334 $1.68 Million
Q4 2019 Jan 31, 2020	BUY	$126.05 - $152.76 $464,368 - $562,767	3,684 Added 83.63%	8,089 $1.24 Million
Q3 2019 Nov 08, 2019	BUY	$125.07 - $143.67 $550,933 - $632,866	4,405 New	4,405 $583,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Charles River Laboratories International, Inc. Transaction History